|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 487/04 | (2006.01) |
| C07B 59/00 | (2006.01) | ||
| A61K 31/519 | (2006.01) | ||
| A61P 35/02 | (2006.01) |
| (11) | Number of the document | 3450434 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18188152.5 |
| Date of filing the European patent application | 2013-06-14 | |
| (97) | Date of publication of the European application | 2019-03-06 |
| (45) | Date of publication and mention of the grant of the patent | 2021-02-24 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 201261660428 P | 2012-06-15 | US | |
| 201261678795 P | 2012-08-02 | US |
| (72) |
SILVERMAN, I. Robert, US
LIU, Julie F., US
MORGAN, Adam J., US
PANDYA, Bhaumik, US
HARBESON, Scott L., US
|
| (73) |
CoNCERT Pharmaceuticals, Inc.,
65 Hayden Avenue, Suite 3000N, Lexington, MA 02421,
US
|
| (54) | DEUTERATED DERIVATIVES OF RUXOLITINIB |
| DEUTERATED DERIVATIVES OF RUXOLITINIB |